Biointelect

Biointelect, a wholly owned subsidiary of Biotech Capital Limited (ASX code: BTC), is a strategic planning and commercialisation consultancy. We provide a range of services for biopharmaceutical, medical device and IVD companies seeking to commercialise new technologies globally. Our clients are either entering new markets or new therapeutic areas, and need to adapt their organisation and business processes to optimise their effectiveness, or have limited resources to be able to focus and effectively execute key projects. Biointelect helps clients to develop and drive strategy, identify and evaluate new business opportunities and find the right partners.